Novartis' Patent Case in India
Monday, July 13, 2009 - 11:49
in Mathematics & Economics
For the third time, an Indian court has ruled that Novartis' patent on the cancer drug Gleevec is not valid in India.
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via